In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
It’s the first time regulators have authorized sales of the products, which are the fastest-growing segment of the tobacco ...
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a ...
The FDA gave marketing authorization to 20 different Zyn products, the most popular nicotine pouch product in the U.S.
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.